HEADER TRANSFERASE 18-FEB-05 1YWN TITLE VEGFR2 IN COMPLEX WITH A NOVEL 4-AMINO-FURO[2,3-D]PYRIMIDINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN; COMPND 5 SYNONYM: VEGFR-2, KINASE INSERT DOMAIN RECEPTOR, PROTEIN-TYROSINE COMPND 6 KINASE RECEPTOR FLK-1; COMPND 7 EC: 2.7.1.112; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES; COMPND 10 OTHER_DETAILS: E990V, DELETION OF RESIDUES 940-989 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: KDR, FLK1; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_CELL_LINE: SF9; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR Y.MIYAZAKI,S.MATSUNAGA,J.TANG,Y.MAEDA,M.NAKANO,R.J.PHILIPPE, AUTHOR 2 M.SHIBAHARA,W.LIU,H.SATO,L.WANG,R.T.NOLTE REVDAT 8 16-OCT-24 1YWN 1 REMARK REVDAT 7 15-NOV-23 1YWN 1 REMARK REVDAT 6 23-AUG-23 1YWN 1 REMARK REVDAT 5 20-OCT-21 1YWN 1 REMARK SEQADV LINK REVDAT 4 11-OCT-17 1YWN 1 REMARK REVDAT 3 13-JUL-11 1YWN 1 VERSN REVDAT 2 24-FEB-09 1YWN 1 VERSN REVDAT 1 23-AUG-05 1YWN 0 JRNL AUTH Y.MIYAZAKI,S.MATSUNAGA,J.TANG,Y.MAEDA,M.NAKANO,R.J.PHILIPPE, JRNL AUTH 2 M.SHIBAHARA,W.LIU,H.SATO,L.WANG,R.T.NOLTE JRNL TITL NOVEL 4-AMINO-FURO[2,3-D]PYRIMIDINES AS TIE-2 AND VEGFR2 JRNL TITL 2 DUAL INHIBITORS JRNL REF BIOORG.MED.CHEM.LETT. V. 15 2203 2005 JRNL REFN ISSN 0960-894X JRNL PMID 15837294 JRNL DOI 10.1016/J.BMCL.2005.03.034 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 TITL CRYSTAL STRUCTURE OF THE KINASE DOMAIN OF HUMAN VASCULAR REMARK 1 TITL 2 ENDOTHELIAL GROWTH FACTOR RECEPTOR 2: A KEY ENZYME IN REMARK 1 TITL 3 ANGIOGENESIS REMARK 1 REF STRUCTURE V. 7 319 1999 REMARK 1 REFN ISSN 0969-2126 REMARK 2 REMARK 2 RESOLUTION. 1.71 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0005 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.71 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.89 REMARK 3 DATA CUTOFF (SIGMA(F)) : -3.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 95.2 REMARK 3 NUMBER OF REFLECTIONS : 35577 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.206 REMARK 3 R VALUE (WORKING SET) : 0.205 REMARK 3 FREE R VALUE : 0.230 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1139 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.71 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.75 REMARK 3 REFLECTION IN BIN (WORKING SET) : 2005 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 73.88 REMARK 3 BIN R VALUE (WORKING SET) : 0.2270 REMARK 3 BIN FREE R VALUE SET COUNT : 63 REMARK 3 BIN FREE R VALUE : 0.2590 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2264 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 39 REMARK 3 SOLVENT ATOMS : 209 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : 25.20 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 32.12 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.12000 REMARK 3 B22 (A**2) : 1.12000 REMARK 3 B33 (A**2) : -1.24000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.113 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.107 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.071 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.206 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.953 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.944 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2360 ; 0.012 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 2148 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3195 ; 1.485 ; 1.991 REMARK 3 BOND ANGLES OTHERS (DEGREES): 4983 ; 0.823 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 277 ; 5.922 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 104 ;32.683 ;22.981 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 409 ;12.752 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 18 ;16.288 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 342 ; 0.085 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2570 ; 0.006 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 506 ; 0.005 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 477 ; 0.219 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 2072 ; 0.188 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 1165 ; 0.188 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 1208 ; 0.086 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 136 ; 0.210 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 13 ; 0.229 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 61 ; 0.205 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 23 ; 0.168 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1805 ; 1.213 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 567 ; 0.218 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2255 ; 1.365 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1152 ; 2.214 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 940 ; 3.067 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 818 A 920 REMARK 3 ORIGIN FOR THE GROUP (A): 2.1180 34.2230 6.1800 REMARK 3 T TENSOR REMARK 3 T11: -0.1108 T22: -0.0080 REMARK 3 T33: -0.0747 T12: -0.0011 REMARK 3 T13: 0.0002 T23: -0.0120 REMARK 3 L TENSOR REMARK 3 L11: 1.9558 L22: 2.4370 REMARK 3 L33: 2.9376 L12: 0.1241 REMARK 3 L13: -0.5716 L23: 0.4925 REMARK 3 S TENSOR REMARK 3 S11: 0.0214 S12: 0.0724 S13: 0.0571 REMARK 3 S21: -0.0612 S22: 0.0050 S23: 0.2199 REMARK 3 S31: -0.0261 S32: -0.0804 S33: -0.0265 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 921 A 1169 REMARK 3 ORIGIN FOR THE GROUP (A): 7.6840 41.4310 32.3890 REMARK 3 T TENSOR REMARK 3 T11: -0.1049 T22: 0.0431 REMARK 3 T33: -0.1020 T12: -0.0155 REMARK 3 T13: 0.0056 T23: -0.0367 REMARK 3 L TENSOR REMARK 3 L11: 1.7237 L22: 1.6632 REMARK 3 L33: 2.6364 L12: 0.2735 REMARK 3 L13: 0.5084 L23: 0.9058 REMARK 3 S TENSOR REMARK 3 S11: -0.0551 S12: -0.0696 S13: -0.0434 REMARK 3 S21: 0.0610 S22: -0.0367 S23: 0.0696 REMARK 3 S31: 0.0962 S32: -0.2470 S33: 0.0918 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1YWN COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 02-MAR-05. REMARK 100 THE DEPOSITION ID IS D_1000032005. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-MAY-01 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : SI 111 REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MAR REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 37357 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.700 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.7 REMARK 200 DATA REDUNDANCY : 6.430 REMARK 200 R MERGE (I) : 0.04700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 31.3800 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.76 REMARK 200 COMPLETENESS FOR SHELL (%) : 71.8 REMARK 200 DATA REDUNDANCY IN SHELL : 4.30 REMARK 200 R MERGE FOR SHELL (I) : 0.38300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.630 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1Y6A REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.54 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.39 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: VAPOR DIFFUSION, HANGING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 18.97650 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 47.90150 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 47.79750 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 47.90150 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 18.97650 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 47.79750 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 804 REMARK 465 ASP A 805 REMARK 465 PRO A 806 REMARK 465 ASP A 807 REMARK 465 GLU A 808 REMARK 465 LEU A 809 REMARK 465 PRO A 810 REMARK 465 LEU A 811 REMARK 465 ASP A 812 REMARK 465 GLU A 813 REMARK 465 HIS A 814 REMARK 465 CYS A 815 REMARK 465 GLU A 816 REMARK 465 ARG A 817 REMARK 465 LYS A 869 REMARK 465 GLU A 870 REMARK 465 GLY A 871 REMARK 465 ALA A 872 REMARK 465 TYR A 936 REMARK 465 LYS A 937 REMARK 465 VAL A 988 REMARK 465 ALA A 989 REMARK 465 PRO A 990 REMARK 465 GLU A 991 REMARK 465 ASP A 992 REMARK 465 LEU A 993 REMARK 465 TYR A 994 REMARK 465 LYS A 995 REMARK 465 ASP A 996 REMARK 465 PHE A 1045 REMARK 465 GLY A 1046 REMARK 465 LEU A 1047 REMARK 465 ALA A 1048 REMARK 465 ARG A 1049 REMARK 465 ASP A 1050 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 SG CYS A 1005 O HOH A 202 2.13 REMARK 500 O PRO A 819 O HOH A 193 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 856 -9.26 75.28 REMARK 500 ALA A 858 49.41 -83.07 REMARK 500 ARG A1025 -17.60 82.87 REMARK 500 ASP A1026 59.51 -146.56 REMARK 500 SER A1035 -168.18 -108.28 REMARK 500 ARG A1078 38.47 34.33 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE LIF A 301 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1VR2 RELATED DB: PDB REMARK 900 VEGFR2 KINASE DOMAIN - UNLIGANDED STRUCTURE REMARK 900 RELATED ID: 1Y6A RELATED DB: PDB REMARK 900 VEGFR2 IN COMPLEX WITH A 2-ANILINO-5-ARYL-OXAZOLE INHIBITOR REMARK 900 RELATED ID: 1Y6B RELATED DB: PDB REMARK 900 VEGFR2 IN COMPLEX WITH A 2-ANILINO-5-ARYL-OXAZOLE INHIBITOR REMARK 999 REMARK 999 SEQUENCE REMARK 999 DELETION OF RESIDUES 938-987 (CORRESPONDS TO DBREF 940-989) DBREF 1YWN A 804 1169 UNP P35968 VGFR2_HUMAN 806 1171 SEQADV 1YWN VAL A 988 UNP P35968 GLU 990 ENGINEERED MUTATION SEQADV 1YWN PTR A 1052 UNP P35968 TYR 1054 MODIFIED RESIDUE SEQADV 1YWN PTR A 1057 UNP P35968 TYR 1059 MODIFIED RESIDUE SEQRES 1 A 316 MET ASP PRO ASP GLU LEU PRO LEU ASP GLU HIS CYS GLU SEQRES 2 A 316 ARG LEU PRO TYR ASP ALA SER LYS TRP GLU PHE PRO ARG SEQRES 3 A 316 ASP ARG LEU LYS LEU GLY LYS PRO LEU GLY ARG GLY ALA SEQRES 4 A 316 PHE GLY GLN VAL ILE GLU ALA ASP ALA PHE GLY ILE ASP SEQRES 5 A 316 LYS THR ALA THR CYS ARG THR VAL ALA VAL LYS MET LEU SEQRES 6 A 316 LYS GLU GLY ALA THR HIS SER GLU HIS ARG ALA LEU MET SEQRES 7 A 316 SER GLU LEU LYS ILE LEU ILE HIS ILE GLY HIS HIS LEU SEQRES 8 A 316 ASN VAL VAL ASN LEU LEU GLY ALA CYS THR LYS PRO GLY SEQRES 9 A 316 GLY PRO LEU MET VAL ILE VAL GLU PHE CYS LYS PHE GLY SEQRES 10 A 316 ASN LEU SER THR TYR LEU ARG SER LYS ARG ASN GLU PHE SEQRES 11 A 316 VAL PRO TYR LYS VAL ALA PRO GLU ASP LEU TYR LYS ASP SEQRES 12 A 316 PHE LEU THR LEU GLU HIS LEU ILE CYS TYR SER PHE GLN SEQRES 13 A 316 VAL ALA LYS GLY MET GLU PHE LEU ALA SER ARG LYS CYS SEQRES 14 A 316 ILE HIS ARG ASP LEU ALA ALA ARG ASN ILE LEU LEU SER SEQRES 15 A 316 GLU LYS ASN VAL VAL LYS ILE CYS ASP PHE GLY LEU ALA SEQRES 16 A 316 ARG ASP ILE PTR LYS ASP PRO ASP PTR VAL ARG LYS GLY SEQRES 17 A 316 ASP ALA ARG LEU PRO LEU LYS TRP MET ALA PRO GLU THR SEQRES 18 A 316 ILE PHE ASP ARG VAL TYR THR ILE GLN SER ASP VAL TRP SEQRES 19 A 316 SER PHE GLY VAL LEU LEU TRP GLU ILE PHE SER LEU GLY SEQRES 20 A 316 ALA SER PRO TYR PRO GLY VAL LYS ILE ASP GLU GLU PHE SEQRES 21 A 316 CYS ARG ARG LEU LYS GLU GLY THR ARG MET ARG ALA PRO SEQRES 22 A 316 ASP TYR THR THR PRO GLU MET TYR GLN THR MET LEU ASP SEQRES 23 A 316 CYS TRP HIS GLY GLU PRO SER GLN ARG PRO THR PHE SER SEQRES 24 A 316 GLU LEU VAL GLU HIS LEU GLY ASN LEU LEU GLN ALA ASN SEQRES 25 A 316 ALA GLN GLN ASP MODRES 1YWN PTR A 1052 TYR O-PHOSPHOTYROSINE MODRES 1YWN PTR A 1057 TYR O-PHOSPHOTYROSINE HET PTR A1052 16 HET PTR A1057 16 HET LIF A 301 39 HETNAM PTR O-PHOSPHOTYROSINE HETNAM LIF N-{4-[4-AMINO-6-(4-METHOXYPHENYL)FURO[2,3-D]PYRIMIDIN- HETNAM 2 LIF 5-YL]PHENYL}-N'-[2-FLUORO-5-(TRIFLUOROMETHYL) HETNAM 3 LIF PHENYL]UREA HETSYN PTR PHOSPHONOTYROSINE HETSYN LIF N-(4-{4-AMINO-6-[4-(METHYLOXY)PHENYL]FURO[2,3- HETSYN 2 LIF D]PYRIMIDIN-5-YL}PHENYL)-N'-[2-FLUORO-5- HETSYN 3 LIF (TRIFLUOROMETHYL)PHENYL]UREA FORMUL 1 PTR 2(C9 H12 N O6 P) FORMUL 2 LIF C27 H19 F4 N5 O3 FORMUL 3 HOH *209(H2 O) HELIX 1 1 ASP A 821 GLU A 826 1 6 HELIX 2 2 PRO A 828 ASP A 830 5 3 HELIX 3 3 THR A 873 GLY A 891 1 19 HELIX 4 4 ASN A 921 LYS A 929 1 9 HELIX 5 5 ARG A 930 PHE A 933 5 4 HELIX 6 6 THR A 999 ARG A 1020 1 22 HELIX 7 7 ALA A 1028 ARG A 1030 5 3 HELIX 8 8 GLU A 1036 ASN A 1038 5 3 HELIX 9 9 LEU A 1065 MET A 1070 5 6 HELIX 10 10 ALA A 1071 ARG A 1078 1 8 HELIX 11 11 THR A 1081 SER A 1098 1 18 HELIX 12 12 ASP A 1110 GLY A 1120 1 11 HELIX 13 13 THR A 1130 TRP A 1141 1 12 HELIX 14 14 GLU A 1144 ARG A 1148 5 5 HELIX 15 15 THR A 1150 ALA A 1166 1 17 SHEET 1 A 5 LEU A 832 ARG A 840 0 SHEET 2 A 5 GLN A 845 PHE A 852 -1 O VAL A 846 N GLY A 839 SHEET 3 A 5 CYS A 860 MET A 867 -1 O ARG A 861 N ALA A 851 SHEET 4 A 5 MET A 911 GLU A 915 -1 O VAL A 912 N LYS A 866 SHEET 5 A 5 LEU A 899 CYS A 903 -1 N LEU A 900 O ILE A 913 SHEET 1 B 2 ILE A1032 LEU A1034 0 SHEET 2 B 2 VAL A1040 ILE A1042 -1 O LYS A1041 N LEU A1033 LINK C ILE A1051 N PTR A1052 1555 1555 1.34 LINK C PTR A1052 N LYS A1053 1555 1555 1.33 LINK C ASP A1056 N PTR A1057 1555 1555 1.33 LINK C PTR A1057 N VAL A1058 1555 1555 1.33 SITE 1 AC1 18 HOH A 127 LEU A 838 GLY A 839 ARG A 840 SITE 2 AC1 18 GLY A 841 VAL A 846 ALA A 864 GLU A 883 SITE 3 AC1 18 VAL A 896 VAL A 897 GLU A 915 PHE A 916 SITE 4 AC1 18 CYS A 917 LEU A1017 HIS A1024 ILE A1042 SITE 5 AC1 18 CYS A1043 ASP A1044 CRYST1 37.953 95.595 95.803 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.026348 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010461 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010438 0.00000